Clonmel Healthcare Ltd., PharOS Mt, STADA Arzneimittel AG, STADA Arzneimittel AG

The medicine is intended for adult men with prostate cancer. It is used in cases where the tumor does not respond to hormonal therapy or testosterone-lowering surgical treatment, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels and the cancer has not spread beyond the prostate.

Dosage form: tablets, film-coated

ATC: L02BB04

The medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormone therapy or testosterone-lowering treatments, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels but the cancer has not metastasized.

Dosage form: tablets, film-coated

ATC: L02BB04